(Q43986685)

English

Posaconazole versus fluconazole or itraconazole for prevention of invasive fungal infections in patients undergoing intensive cytotoxic therapy for acute myeloid leukemia or myelodysplasia: a cost effectiveness analysis

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Posaconazole versus fluconazole or itraconazole for prevention of invasive fungal infections in patients undergoing intensive cytotoxic therapy for acute myeloid leukemia or myelodysplasia: a cost effectiveness analysis (English)

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

acute myeloid leukemia

1 reference

based on heuristic

inferred from title

invasive fungal infections

1 reference

based on heuristic

inferred from title

George Dranitsaris

1

object named as

George Dranitsaris

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

author name string

Haytham Khoury

2

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

publication date

23 October 2010

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Supportive Care in Cancer

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

19

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

11

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

1807-1813

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

https://scigraph.springernature.com/pub.10.1007/s00520-010-1022-7

0 references

Considerations in the approach to invasive fungal infection in patients with haematological malignancies

1 reference

https://api.crossref.org/works/10.1007%2FS00520-010-1022-7

21 January 2018

Impaired gut function as risk factor for invasive candidiasis in neutropenic patients

1 reference

https://api.crossref.org/works/10.1007%2FS00520-010-1022-7

21 January 2018

Intestinal mucosal dysfunction and infection during remission-induction therapy for acute myeloid leukaemia

1 reference

https://api.crossref.org/works/10.1007%2FS00520-010-1022-7

21 January 2018

Neutropenic fever syndromes in patients undergoing cytotoxic therapy for acute leukemia and myelodysplastic syndromes

1 reference

https://api.crossref.org/works/10.1007%2FS00520-010-1022-7

21 January 2018

Antifungal prophylaxis for severely neutropenic chemotherapy recipients: a meta analysis of randomized-controlled clinical trials

1 reference

https://api.crossref.org/works/10.1007%2FS00520-010-1022-7

21 January 2018

Antifungal prophylaxis in cancer patients after chemotherapy or hematopoietic stem-cell transplantation: systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1007%2FS00520-010-1022-7

21 January 2018

Posaconazole vs. fluconazole or itraconazole prophylaxis in patients with neutropenia

1 reference

https://api.crossref.org/works/10.1007%2FS00520-010-1022-7

21 January 2018

Diagnostic and therapeutic approach to persistent or recurrent fevers of unknown origin in adult stem cell transplantation and haematological malignancy

1 reference

https://api.crossref.org/works/10.1007%2FS00520-010-1022-7

21 January 2018

Empirical antifungal therapy in patients with neutropenia and persistent or recurrent fever of unknown origin

1 reference

https://api.crossref.org/works/10.1007%2FS00520-010-1022-7

21 January 2018

Micafungin versus fluconazole for prophylaxis against invasive fungal infections during neutropenia in patients undergoing hematopoietic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1007%2FS00520-010-1022-7

21 January 2018

The direct cost and incidence of systemic fungal infections

1 reference

https://api.crossref.org/works/10.1007%2FS00520-010-1022-7

21 January 2018

Cost-effectiveness of posaconazole versus fluconazole or itraconazole in the prevention of invasive fungal infections among neutropenic patients in the United States.

1 reference

https://api.crossref.org/works/10.1007%2FS00520-010-1022-7

21 January 2018

Efficacy does not necessarily translate to cost effectiveness: a case study in the challenges associated with 21st-century cancer drug pricing.

1 reference

https://api.crossref.org/works/10.1007%2FS00520-010-1022-7

21 January 2018

How much is life worth: cetuximab, non-small cell lung cancer, and the $440 billion question

1 reference

https://api.crossref.org/works/10.1007%2FS00520-010-1022-7

21 January 2018

Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America

1 reference

https://api.crossref.org/works/10.1007%2FS00520-010-1022-7

21 January 2018

Revisiting the Source of Candidemia: Skin or Gut?

1 reference

https://api.crossref.org/works/10.1007%2FS00520-010-1022-7

21 January 2018

Prolonged granulocytopenia: the major risk factor for invasive pulmonary aspergillosis in patients with acute leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/20972589

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A Double-Blind, Randomized, Placebo-Controlled Trial of Itraconazole Capsules as Antifungal Prophylaxis for Neutropenic Patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/20972589

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Invasive Pulmonary Aspergillosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/20972589

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Invasive aspergillosis outbreak on a hematology-oncology ward

1 reference

https://pubmed.ncbi.nlm.nih.gov/20972589

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00520-010-1022-7

1 reference

https://api.fatcat.wiki/v0/release/bjcjzgxsknec3lqg6x6jx2game

30 July 2022

based on heuristic

mapped directly with Wikidata item

Dimensions Publication ID

0 references

release_bjcjzgxsknec3lqg6x6jx2game

1 reference

https://api.fatcat.wiki/v0/release/bjcjzgxsknec3lqg6x6jx2game

30 July 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

https://api.fatcat.wiki/v0/release/bjcjzgxsknec3lqg6x6jx2game

30 July 2022

based on heuristic

mapped directly with Wikidata item

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43986685&oldid=2105327599"